This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Popovici, R. M. Articles by Giudice, L. C. Search for Related Content PubMed PubMed Citation Articles by Popovici, R. M. Articles by Giudice, L. C.

Hypoxia Regulates Insulin-Like Growth Factor-Binding Protein 1 in Human Fetal Hepatocytes in Primary Culture: Suggestive Molecular Mechanisms for in Utero Fetal Growth Restriction Caused by Uteroplacental Insufficiency¹

Departments of Gynecology and Obstetrics (R.M.P., M.L., G.H.F., L.C.G.), Pediatrics (S.B.), and Radiation Oncology (A.J.G.), Stanford University Medical School, Stanford, California 94305; and Department of Gynecological Endocrinology and Reproductive Medicine (R.M.P.), Ruprecht-Karls University, Heidelberg, Germany

Address all correspondence and requests for reprints to: Linda C. Giudice, Ph.D., M.D., Division of Reproductive Endocrinology and Infertility Center for Research on Women’s Health and Reproductive Medicine, Department Gynecology and Obstetrics, Stanford University Medical Center, Room HH-333, Stanford, California 94305-5317. E-mail: giudice{at}stanford.edu

Abstract

Intrauterine growth restriction (IUGR) can be a consequence of decreased uterine blood flow (uteroplacental insufficiency) and maternal and fetal hypoxia. Insulin-like growth factors (IGFs) and their binding proteins (IGFBPs) are key elements in fetal growth. IGF-I is a major growth promoter in utero. IGFBP-1 is primarily made in the liver, and it mostly inhibits IGF actions at the cellular level. IGFBP-1 is elevated in the fetal circulation of human and animal pregnancies complicated by IUGR caused by placental insufficiency and in utero hypoxia and is believed to restrict fetal growth by sequestering IGFs. In this study, we developed a protocol to establish highly pure primary cultures of human fetal hepatocytes in vitro and investigated their expression of IGFBP-1 messenger RNA (mRNA) and protein and the effects of hypoxia on their expression of IGFBP-1 mRNA and protein. Hepatocytes were isolated from second-trimester human fetal livers (n = 7) and purified by Percoll gradient centrifugation. Hepatocyte cultures were characterized by immunocytochemistry and were compared with hepatocytes in situ in human fetal liver tissue, by immunohistochemistry, using specific antibodies and indirect immunofluorescence. Cultures consisted primarily (>90%) of cells positive for cytokeratin 18, fibrinogen, and IGFBP-1, with less than 2% vascular cells and less than 8% macrophages. Identification of isolated hepatocytes was further confirmed by morphology. Hepatocytes were cultured in defined medium, and Northern analysis revealed expression of a 1.5-kb IGFBP-1 mRNA transcript in hepatocytes cultured under normoxic conditions, for 24 h, that did not increase in steady-state levels after 48 h in culture. Under hypoxic conditions (2% O₂), IGFBP-1 mRNA expression increased 3- to 4-fold, compared with normoxic controls. Cells cultured under 10% O₂ did not demonstrate an increase in IGFBP-1 mRNA levels. IGFBP-1 protein in conditioned medium (CM) was measured by immunoradiometric assay and increased 3- to 4-fold under hypoxic (2% O₂), compared with normoxic, conditions. Western ligand blot analysis of CM revealed the presence of IGFBP-1, IGFBP-2, IGFBP-3, and IGFBP-4. IGFBP-1 was the most abundant IGFBP in CM, and densitometric analysis revealed a 2.5-fold increase in IGFBP-1 under hypoxic, compared with normoxic, conditions, supporting the immunoradiometric assay results. A 3-fold increase in IGFBP-3 mRNA, but not other IGFBPs, was noted under hypoxic, compared with normoxic, conditions. This study demonstrates that human fetal hepatocytes can be cultured in defined medium, as primary cultures with high purity, and that they express IGFBP-1 mRNA and secrete IGFBP-1 protein in vitro. In addition, the data demonstrate that hypoxia up-regulates fetal hepatocyte IGFBP-1 mRNA steady-state levels and protein, with this being the major IGFBP derived from the fetal hepatocyte. The data support a role for the fetal liver as a source of elevated circulating levels of IGFBP-1 in fetuses with in utero hypoxia and IUGR.

This article has been cited by other articles:

				M. D. Seferovic, R. Ali, H. Kamei, S. Liu, J. M. Khosravi, S. Nazarian, V. K. M. Han, C. Duan, and M. B. Gupta Hypoxia and Leucine Deprivation Induce Human Insulin-Like Growth Factor Binding Protein-1 Hyperphosphorylation and Increase Its Biological Activity Endocrinology, January 1, 2009; 150(1): 220 - 231. [Abstract] [Full Text] [PDF]

				M. Ream, A. M. Ray, R. Chandra, and D. M. Chikaraishi Early fetal hypoxia leads to growth restriction and myocardial thinning Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2008; 295(2): R583 - R595. [Abstract] [Full Text] [PDF]

				X.-Q. Chen, S.-J. Wang, J.-Z. Du, and X.-C. Chen Diversities in hepatic HIF-1, IGF-I/IGFBP-1, LDH/ICD, and their mRNA expressions induced by CoCl2 in Qinghai-Tibetan plateau mammals and sea level mice Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R516 - R526. [Abstract] [Full Text] [PDF]

				R. M. Popovici, N. K. Betzler, M. S. Krause, M. Luo, J. Jauckus, A. Germeyer, S. Bloethner, A. Schlotterer, R. Kumar, T. Strowitzki, et al. Gene Expression Profiling of Human Endometrial-Trophoblast Interaction in a Coculture Model Endocrinology, December 1, 2006; 147(12): 5662 - 5675. [Abstract] [Full Text] [PDF]

				A L Pierce, M Shimizu, L Felli, P Swanson, and W W Dickhoff Metabolic hormones regulate insulin-like growth factor binding protein-1 mRNA levels in primary cultured salmon hepatocytes; lack of inhibition by insulin. J. Endocrinol., November 1, 2006; 191(2): 379 - 386. [Abstract] [Full Text] [PDF]

				M. E Street, P. Seghini, S. Fieni, M. A. Ziveri, C. Volta, D. Martorana, I. Viani, D. Gramellini, and S. Bernasconi Changes in interleukin-6 and IGF system and their relationships in placenta and cord blood in newborns with fetal growth restriction compared with controls. Eur. J. Endocrinol., October 1, 2006; 155(4): 567 - 574. [Abstract] [Full Text] [PDF]

				S. Kajimura, K. Aida, and C. Duan Understanding Hypoxia-Induced Gene Expression in Early Development: In Vitro and In Vivo Analysis of Hypoxia-Inducible Factor 1-Regulated Zebra Fish Insulin-Like Growth Factor Binding Protein 1 Gene Expression Mol. Cell. Biol., February 1, 2006; 26(3): 1142 - 1155. [Abstract] [Full Text] [PDF]

				J.-G. Scharf, T. G. Unterman, and T. Kietzmann Oxygen-Dependent Modulation of Insulin-Like Growth Factor Binding Protein Biosynthesis in Primary Cultures of Rat Hepatocytes Endocrinology, December 1, 2005; 146(12): 5433 - 5443. [Abstract] [Full Text] [PDF]

				A. Grimberg, C. M. Coleman, T. F. Burns, B. P. Himelstein, C. J. Koch, P. Cohen, and W. S. El-Deiry p53-Dependent and p53-Independent Induction of Insulin-Like Growth Factor Binding Protein-3 by Deoxyribonucleic Acid Damage and Hypoxia J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3568 - 3574. [Abstract] [Full Text] [PDF]

				S. Kajimura, K. Aida, and C. Duan From the Cover: Insulin-like growth factor-binding protein-1 (IGFBP-1) mediates hypoxia-induced embryonic growth and developmental retardation PNAS, January 25, 2005; 102(4): 1240 - 1245. [Abstract] [Full Text] [PDF]

				D. E. Hansel, A. Rahman, M. House, R. Ashfaq, K. Berg, C. J. Yeo, and A. Maitra Met Proto-Oncogene and Insulin-Like Growth Factor Binding Protein 3 Overexpression Correlates with Metastatic Ability in Well-Differentiated Pancreatic Endocrine Neoplasms Clin. Cancer Res., September 15, 2004; 10(18): 6152 - 6158. [Abstract] [Full Text] [PDF]

				R. M. Douglas and G. G. Haddad Genetic Models in Applied Physiology: Invited Review: Effect of oxygen deprivation on cell cycle activity: a profile of delay and arrest J Appl Physiol, May 1, 2003; 94(5): 2068 - 2083. [Abstract] [Full Text] [PDF]

				E. Kajantie, C. H. D. Fall, M. Seppala, R. Koistinen, L. Dunkel, H. Yliharsila, C. Osmond, S. Andersson, D. J. P. Barker, T. Forsen, et al. Serum Insulin-like Growth Factor (IGF)-I and IGF-Binding Protein-1 in Elderly People: Relationships with Cardiovascular Risk Factors, Body Composition, Size at Birth, and Childhood Growth J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1059 - 1065. [Abstract] [Full Text] [PDF]

				T. J. Maures and C. Duan Structure, Developmental Expression, and Physiological Regulation of Zebrafish IGF Binding Protein-1 Endocrinology, July 1, 2002; 143(7): 2722 - 2731. [Abstract] [Full Text] [PDF]